Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atea Pharmaceuticals IncfiledCriticalAtea Pharmaceuticals Inc
Publication of AR111017A1publicationCriticalpatent/AR111017A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Una sal hemisulfato con la estructura de fórmula (1) para tratar un huésped infectado con el virus de la hepatitis C así como composiciones y formas de dosificación del mismo, que incluyen formas de dosificación sólidas.A hemisulfate salt with the structure of formula (1) to treat a host infected with the hepatitis C virus as well as compositions and dosage forms thereof, which include solid dosage forms.
ARP180100244A2017-02-012018-02-01
HEMISULFATE SALT OF A NUCLEOTID COMPOUND FOR THE TREATMENT OF HEPATITIS C VIRUS
AR111017A1
(en)